MeiraGTx Holdings plc

MGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017
Operating Activities
Net Income $-31.0M
Depreciation & Amortization —
Depreciation $679.2K
Amortization —
Stock-Based Compensation $3.0M
Net Cash from Operating Activities $-18.1M
Investing Activities
Capital Expenditures $10.5M
Business Acquisitions —
Net Cash from Investing Activities $-10.5M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $19.3M
Net Change in Cash —
Free Cash Flow $-28.6M
← Newer Page 2 of 2 Older →